All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Are Glp-1 Drugs Approved for Teens

Are Glp-1 Drugs Approved for Teens. Evidence-based answers from Form Blends, a physician-supervised telehealth weight loss clinic.

By FormBlends Editorial Research||
In This Article

This article is part of our Quick Answers collection. See also: GLP-1 Guides | Provider Comparisons

Key Takeaway

See your personalized options in about 2 minutes. Free and private. See my options →

Are Glp-1 Drugs Approved for Teens. Evidence-based answers from FormBlends, a physician-supervised telehealth weight loss clinic.

Several GLP-1 receptor agonists have received FDA approval for teens with obesity. Saxenda (liraglutide) was approved for adolescents 12-17 years old in 2020, while Wegovy (semaglutide) gained approval for teens in December 2022. These approvals followed dedicated pediatric trials showing significant weight reduction, with semaglutide achieving 16.1% weight loss versus 0.6% placebo in the STEP TEENS trial.

Here is what the current medical evidence says about are GLP-1 drugs approved for teens. At FormBlends, our physicians stay on top of the latest research to give patients clear, actionable information. Below we break down what you need to know, based on clinical data and our clinical experience.

What Does the Research Say About Are Glp-1 Drugs Approved for Teens?

The medical literature on are GLP-1 drugs approved for teens provides several key findings:

  • GLP-1 receptor agonists work by mimicking natural gut hormones that regulate appetite and blood sugar
  • Clinical trials have shown consistent weight loss results across diverse patient populations
  • Side effects are primarily gastrointestinal and tend to improve during the first weeks of treatment
  • Physician supervision is important for monitoring progress and adjusting dosing

How Does This Apply to Your Treatment?

Understanding are GLP-1 drugs approved for teens matters because it directly affects treatment decisions. At FormBlends, our physicians consider this information when building your personalized protocol. Every patient is different, and what works for one person may need adjustment for another.

Most Common GLP-1 Questions by Category Search Volume Share (%) 0 8 17 26 35 35 28 22 15 Side Effects Cost/Insurance Effectiveness Eligibility Based on search query analysis, 2026
Most Common GLP-1 Questions by Category. Based on search query analysis, 2026.
View data table
Bar chart showing most common glp-1 questions by category: Side Effects (35), Cost/Insurance (28), Effectiveness (22), Eligibility (15)
CategorySearch Volume Share (%)Detail
Side Effects35Nausea, GI issues
Cost/Insurance28Pricing questions
Effectiveness22How much weight loss
Eligibility15BMI requirements
Illustration for Are Glp-1 Drugs Approved for Teens

We recommend discussing are GLP-1 drugs approved for teens with your FormBlends physician during your consultation. They can explain how it applies to your specific health history and weight loss goals.

FDA-Approved GLP-1 Medications for Adolescents

Semaglutide (Wegovy) received teen approval after the STEP TEENS trial enrolled 201 participants aged 12-18 with obesity. Weekly 2.4mg injections over 68 weeks produced 16.1% mean weight reduction compared to 0.6% with placebo. The study used identical dosing to adults, starting at 0.25mg weekly and escalating to 2.4mg over 16 weeks. Gastrointestinal side effects occurred in 71% of teens on semaglutide versus 42% on placebo, with nausea being most common at 38%.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Liraglutide (Saxenda) gained adolescent approval based on the Ellipse trial with 251 teens receiving daily 3mg injections for 56 weeks. Participants lost 5.3 kg on average while placebo group gained 1.6 kg. Both medications activate GLP-1 receptors in the hypothalamus, reducing appetite by 20-30% while delaying gastric emptying by 2-3 hours. Tirzepatide trials in teens began in 2023, with dual GIP/GLP-1 receptor activation potentially offering superior weight loss compared to single-receptor agonists.

Clinical Evidence: Teen GLP-1 Approval

The STEP TEENS trial demonstrated semaglutide reduced BMI by 16.1% in adolescents over 68 weeks. Liraglutide produced 5.3 kg weight loss versus placebo weight gain in the Ellipse study with 251 teens.

What Should You Do Next?

If you have questions about are GLP-1 drugs approved for teens, FormBlends can help. Our licensed physicians provide personalized guidance based on your medical history and goals. Start with a free online evaluation to connect with a provider who can answer your specific questions.

  • Semaglutide for weight loss
  • Tirzepatide for weight loss
  • Compounded GLP-1 medications

Get Personalized Answers

General information is a starting point, but your treatment should be tailored to you. FormBlends connects you with licensed physicians who can evaluate your situation and provide specific recommendations. Complete your free evaluation today.

Start Your Free Consultation

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Are Glp-1 Drugs Approved for Teens custom 2026 header image for Quick Answers
Custom header image for Are Glp-1 Drugs Approved for Teens, Quick Answers, and better treatment decision-making.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

Provider decision path

Use local research to choose a safer review path

Related treatment context

Are Glp-1 Drugs Approved for Teens is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

FormBlends for iPhone

Track your routine in the FormBlends app

Doses, schedules, reminders, meals and progress in one free iPhone app.

Free Tools

Calculators to support your weight loss journey.